Epcoritamab,rituximab,cyclophosphamide,doxorubicin,vincristine,prednisone,lenalidomide,bendamustine,cytarabine,dexamethasone,oxaliplatin,carboplatin,gemcitabine,ifosfamide
Genmab,Abbvie
['epcore,nhl,2', 'follicular', 'epcoritamab', 'nhl', 'epcore,nhl,i,(-ii)', 'lymphoma', 'epcore,nhl,3', 'genmab', 'abbvie']
genmab reveals promising data from epcore nhl-2 trial, with 98% orr and 87% cmr in follicular lymphoma patients. epcoritamab co-developed with abbvie. #genmab #abbvie #eha2023 #positive 
Real-time news analysis & sentiment scoring for the stocks in the S&P500
Powered by @streetbeat_com of @gptnewstracker
Disclosure: https://t.co/sjkSk4W05p